Current Report Filing (8-k)
November 13 2017 - 2:13PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
November 13, 2017
PROPHASE
LABS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
0-21617
|
|
23-2577138
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(I.R.S.
Employer
Identification No.)
|
621
N. Shady Retreat Road, Doylestown, PA, 18901
(Address
of principal executive offices)
(Registrant’s
telephone number, including area code):
(215) 345-0919
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-2)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))
|
Item
2.02 Results of Operations and Financial Condition.
On
November 13, 2017, ProPhase Labs, Inc. (the “Company”) issued a press release announcing its financial results for
the three months and nine months ended September 30, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Form
8-K.
The
information in this Item 2.02 and Exhibits 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any registration statement filed under the Securities
Act of 1933, as amended, unless specifically identified therein as being incorporated by reference therein.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
ProPhase
Labs, Inc.
|
|
|
|
By:
|
/s/
Monica Brady
|
|
|
Monica
Brady
|
|
|
Principal
Accounting Officer
|
Date:
November 13, 2017
Exhibits
Index
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Sep 2023 to Sep 2024